Citations |
Adv Sci (Weinh). 2024 Apr 3:e2309002.<br/>Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1705-1721.<br/>Bioengineered. 2022 Jan;13(1):1320-1334.<br/>Biomed Pharmacother. 2019 Jul;115:108934. <br/>Biomed Pharmacother. 2023 Mar 13;161:114484.<br/>Biomed Res Int. 2021 May 15.<br/>bioRxiv. 2023 Dec 4.<br/>bioRxiv. 2023 Nov 1.<br/>Bosn J Basic Med Sci. 2017 May 20;17(2):132-137.<br/>Cancer Metab. 2024 May 17;12(1):14.<br/>Cancer Res. 2024 Mar 19.<br/>Cardiovasc Diabetol. 2024 May 9;23(1):164.<br/>Cell Commun Signal. 2021 Mar 18;19(1):35.<br/>Evid Based Complement Alternat Med. 2020 Mar 10;2020:3524641.<br/>Exp Ther Med. 2018 Aug;16(2):1079-1086.<br/>Front Cardiovasc Med. 2021 Apr 13;8:654254.<br/>Front Med. 2021 Apr 13;8:634882.<br/>Hum Gene Ther. 2022 Nov 14.<br/>Insect Mol Biol. 2024 Jan 5.<br/>Int Immunopharmacol. 2023 Dec 21:127:111313.<br/>Int J Immunopathol Pharmacol. Jan-Dec 2022;36:3946320221111117.<br/>Int J Mol Sci. 2023 Mar 7.<br/>J Cell Mol Med. 2024 Apr;28(8):1-11.<br/>J Ethnopharmacol. 2022 Jun 17;115476.<br/>J Extracell Vesicles. 2023 May;12(5):e12328.<br/>JCI Insight. 2021 Sep 22;6(18):e133690.<br/>Mediat Inflamm. 2019 Oct 7;2019:6168340.<br/>Mediat Inflamm. 2020 Oct 24;2020:1649453.<br/>Microvasc Res. 2023 Mar 22;148:104531.<br/>Mol Cell Probes. 2023 Feb 2;67:101896.<br/>Nutrients. 2022, 14(23), 5025<br/>PeerJ. 2023 May 25.<br/>Phytomedicine. 6 June 2022, 154242.<br/>Placenta. 12 November 2021.<br/>Placenta. 2021 Feb 11.<br/>Research Square Preprint. 2021 Feb.<br/>Research Square Preprint. 2022 May.<br/>Research Square Preprint. 2023 May 30.<br/>Toxicol Appl Pharmacol. 2019 Mar 1;366:83-95. <br/>Vet Microbiol. 19 July 2022, 109514.<br/>Biomed Pharmacother. 2020 Aug;128:110240.<br/>Cell Tissue Res. 2022 Jan 29.<br/>[1]Pfeiffer S, et al. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement forbioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol. 1996 Jul;118(6):1433-40.<br/>[2]Kopincová J, et al. L-NAME in the cardiovascular system - nitric oxide synthase activator? Pharmacol Rep. 2012;64(3):511-20.<br/>[3]Lo HC, et al. The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis. PLoSOne. 2016 Mar 23;11(3):e0151973.<br/>[4]Luo H, et al. Effect of nitric oxide synthase inhibitor L-NAME on fear extinction in rats: a task-dependent effect. Neurosci Lett. 2014 Jun 20;572:13-8.<br/>[5]Ocsan RJ, et al. Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in c-kit positive cells during development of cardiac hypertrophy. J Physiol Pharmacol. 2013 Dec;64(6):727-36.<br/>[6]V A Peotta, et al. Cardiovascular neural reflexes in L-NAME-induced hypertension in mice. Hypertension. 2001, 38, 3.<br/>[7]Xiaofei Li, et al. Fucoidan from Undaria pinnatifida prevents vascular dysfunction through PI3K/Akt/eNOS-dependent mechanisms in the l-NAME-induced hypertensive rat model. Food Funct. 2016, 7, 5. |